The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Bace1-dependent amyloid processing regulates hypothalamic leptin sensitivity in obese mice
Abstract
Obesity places an enormous medical and economic burden on society. The principal driver appears to be central leptin resistance with hyperleptinemia. Accordingly, a compound that reverses or prevents leptin resistance should promote weight normalisation and improve glucose homeostasis. The protease Bace1 drives beta amyloid (Aβ) production with obesity elevating hypothalamic Bace1 activity and Aβ 1–42 production. Pharmacological inhibition of Bace1 reduces body weight, improves glucose homeostasis and lowers plasma leptin in diet-induced obese (DIO) mice. These actions are not apparent in ob/ob or db/db mice, indicating the requirement for functional leptin signalling. Decreasing Bace1 activity normalises hypothalamic inflammation, lowers PTP1B and SOCS3 and restores hypothalamic leptin sensitivity and pSTAT3 response in obese mice, but does not affect leptin sensitivity in lean mice. Raising central Aβ 1–42 levels in the early stage of DIO increases hypothalamic basal pSTAT3 and reduces the amplitude of the leptin pSTAT3 signal without increased inflammation. Thus, elevated Aβ 1–42 promotes hypothalamic leptin resistance, which is associated with diminished whole-body sensitivity to exogenous leptin and exacerbated body weight gain in high fat fed mice. These results indicate that Bace1 inhibitors, currently in clinical trials for Alzheimer’s disease, may be useful agents for the treatment of obesity and associated diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BACE1 has been implicated in a range of metabolic functions.
“and BACE1 has been implicated in a range of metabolic functions.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]
The influence of BACE1 on insulin signaling is in part through negative regulators PTEN and PTP1B, which are found to decrease in response to BACE1 inhibition.
“The influence of BACE1 on insulin signaling is in part through negative regulators PTEN and PTP1B, which are found to decrease in response to BACE1 inhibition.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]
In addition to insulin signaling, other metabolic changes associated with BACE1 have been observed, including lowered plasma leptin and restored hypothalamic leptin sensitivity in obese mice.
“In addition to insulin signaling, other metabolic changes associated with BACE1 have been observed, including lowered plasma leptin and restored hypothalamic leptin sensitivity in obese mice.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]
Inhibition of BACE1 in DIO mice normalized the STAT3 response, alongside improving glucose homeostasis, reducing hypothalamic inflammation, and normalizing hypothalamic leptin sensitivity via NPY, AgRP, and POMC signaling.
“Inhibition of BACE1 in diet‐induced obese (DIO) mice normalized the STAT3 response, alongside improving glucose homeostasis, reducing hypothalamic inflammation, and normalizing hypothalamic leptin sensitivity via NPY, AgRP, and POMC signaling.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]
Body weight changes in BACE1 knockout and inhibitor-treated mice are likely through increased energy expenditure.
“suggesting body weight changes are likely through increased energy expenditure.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]
Both BACE1 knockout and inhibitor-treated mice show no change in daily food intake while presenting with decreased body weight.
“Interestingly, both BACE1 knockout and inhibitor‐treated mice show no change in daily food intake while presenting with decreased body weight”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]
BACE1 may play a role in the mechanisms behind changes in leptin levels and sensitivity.
“Therefore, BACE1 may play a role in the mechanisms behind changes in leptin levels and sensitivity.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950
Activation of Downstream Signals by the Long Form of the Leptin Receptor
Banks, A. S., Davis, S. M., Bates, S. H., & Myers, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14563 · Cited by 797
Leptin Regulation of Neuroendocrine Systems
Ahima, R. S., Saper, C. B., Flier, J. S., & Elmquist, J. K. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2000.0197 · Cited by 767
Region-Specific Leptin Resistance within the Hypothalamus of Diet-Induced Obese Mice
Münzberg, H., Flier, J. S., & Bjørbæk, C. (2004) · Endocrinology · doi:10.1210/en.2004-0726 · Cited by 737
The Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Tao, Y.-X. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0037 · Cited by 531
Chami, L., & Checler, F. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-52 · Cited by 168
Flagged first, then by citations
Research works printed but not linked: 33
- Stockley, J. H. & O’Neill, C. Understanding BACE1: essential protease for amyloid-β production in Alzheimer’s disease. Cell. Mol. Life Sci. 65, 325–3289 (2008). · DOI
- Pastorino, L. & Lu, K. P. Pathogenic mechanisms in Alzheimer’s disease. Eur. J. Pharmacol. 545, 29–38 (2006). · DOI
- Zhao, J. et al. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer’s disease pathogenesis. J. Neurosci. 27, 3639–3649 (2007). · DOI · Paper page
- Zhao, W. Q. & Townsend, M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s disease. Biochim. Biophys. Acta. 1792, 482–496 (2009). · DOI · Paper page
- Meakin, P. J. et al. Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice. Biochem. J. 441, 285–296 (2012). · DOI · Paper page
- Plucinska, K. et al. Neuronal human BACE1 knockin induces systemic diabetes in mice. Diabetologia 59, 1513–1523 (2016). · DOI · Paper page
- Cowley, M. A. et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480–484 (2001). · DOI · Paper page
- Pinto, S. et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304, 110–115 (2004). · DOI · Paper page
- Frederich, R. C. et al. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1, 1311–1314 (1995). · DOI · Paper page
- Enriori, P. J. et al. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab. 5, 181–194 (2007). · DOI · Paper page
- Simonds, S. E. et al. Leptin mediates the increase in blood pressure associated with obesity. Cell 159, 1404–1416 (2014). · DOI
- De Souza, C. T. et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192–4199 (2005). · DOI · Paper page
- Zhang, X. et al. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61–73 (2008). · DOI · Paper page
- Thaler, J. P. et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153–162 (2012). · DOI · Paper page
- Hosoi, T. et al. Endoplasmic reticulum stress induces leptin resistance. Mol. Pharmacol. 74, 1610–1619 (2008). · DOI
- Ozcan, L. et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 9, 35–51 (2009). · DOI · Paper page
- Myers, M. G. Jr, Leibel, R. L., Seeley, R. J. & Schwartz, M. W. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol. Metab. 21, 643–651 (2010). · DOI
- Zhou, Y. & Rui, L. Leptin signalling and leptin resistance. Front. Med. 7, 207–222 (2013). · DOI · Paper page
- Harrison, S. M. et al. BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioural changes. Mol. Cell. Neurosci. 24, 646–655 (2003). · DOI · Paper page
- Thaler, J. P., Guyenet, S. J., Dorfman, M. D., Wisse, B. E. & Schwartz, M. W. Hypothalamic inflammation: marker of mechanism of obesity pathogenesis? Diabetes 62, 2629–2634 (2013). · DOI
- Cai, D. & Liu, T. Inflammatory cause of metabolic syndrome via brain stress and NF-κB. Aging 4, 98–115 (2012). · DOI
- Eketjäll, S. et al. AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice. J. Neurosci. 33, 10075–10084 (2013). · DOI
- Fonseca, A. C., Ferreiro, E., Oliviera, C. R., Cardoso, S. M. & Pereira, C. F. Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cells. Biochem. Biophys. Acta 1832, 2191–2203 (2013).
- Clarke, J. R. et al. Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation. EMBO Mol. Med. 7, 190–210 (2015). · DOI · Paper page
- Zhang, Y. et al. Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway. Diabetes 61, 1434–1443 (2012). · DOI · Paper page
- Vong, L. et al. Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron 71, 411–420 (2011). · DOI
- Briggs, D. I., Lemus, M. B., Kua, E. & Andrews, Z. B. Diet-induced obesity attenuates fasting-induced hyperphagia. J. Neuroendocrinol. 23, 620–626 (2011). · DOI
- Rezai-Zadeh, K. et al. Leptin receptor neurons in the dorsomedial hypothalamus are key regulators of energy expenditure and body weight, but not food intake. Mol. Metab. 3, 681–693 (2014). · DOI
- Hamilton, D. L. et al. Altered amyloid precursor protein processing regulates glucose uptake and oxidation in cultured rodent myotubes. Diabetologia 57, 1684–1692 (2014). · DOI · Paper page
- Bjorbak, C. et al. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275, 40649–40657 (2000). · DOI · Paper page
- Wilsey, J. & Scarpace, P. J. Caloric restriction reverses the deficits in leptin receptor protein and leptin signalling capacity associated with diet-induced obesity: role of leptin in the regulation of hypothalamic long-form leptin receptor expression. J Endocrinol. 181, 297–306 (2004). · DOI
- Martin, T. L. et al. Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J. Biol. Chem. 281, 18933–18941 (2006). · DOI
- Ottaway, N. et al. Diet-induced obese mice retain endogenous leptin action. Cell Metab. 21, 877–882 (2015). · DOI
Cited by
Sorted by citations
Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin
Flores-Cordero, J. A., Pérez-Pérez, A., Jiménez-Cortegana, C., Alba, G., Flores-Barragán, A., & Sánchez-Margalet, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095202 · Cited by 212
BACE1: More than just a β‐secretase
Taylor, H. A., Przemylska, L., Clavane, E. M., & Meakin, P. J. (2022) · Obesity Reviews · doi:10.1111/obr.13430 · Cited by 107
Self-citation
Metadata
- Authors
- Meakin, P. J., Jalicy, S. M., Montagut, G., Allsop, D. J. P., Cavellini, D. L., Irvine, S. W., McGinley, C., Liddell, M. K., McNeilly, A. D., Parmionova, K., Liu, Y.-R., Bailey, C. L. S., Dale, J. K., Heisler, L. K., McCrimmon, R. J., & Ashford, M. L. J.
- Venue
- Scientific Reports
- Published
- 2018-01-08
- Volume
- 8
- Issue
- 1
- ISSN
- 2045-2322
- PMC
- PMC5758523
- Cited by
- 36
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review